| Dr Anna S Zabrecky, MD | |
|
7495 State Rd, Ste 300, Cincinnati, OH 45255-6402 | |
| (513) 231-3447 | |
| (513) 231-3761 |
| Full Name | Dr Anna S Zabrecky |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 39 Years |
| Location | 7495 State Rd, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033112321 | NPI | - | NPPES |
| 000000021123 | Other | OH | ANTHEM |
| 0744243 | Medicaid | OH | |
| 0701211 | Other | OH | UNITED HEALTCARE |
| 160039310 | Other | OH | MEDICARE RAILROAD |
| 288100 | Other | OH | AMERIGROUP |
| 290685086005 | Other | OH | MEDICAL MUTUAL |
| 54483 | Other | OH | HUMANA |
| 993554 | Other | OH | AETNA |
| 290685860004 | Other | OH | MEDICAL MUTUAL |
| 311575051046 | Other | OH | CARESOURCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35054483Z (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health-anderson Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seven Hills Ob-gyn Associates Llc | 0749188142 | 109 |
News Archive
Working with lab mice models of multiple sclerosis, UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
New research by scientists at the University of Pittsburgh provides an unprecedented level of resolution and insight into disturbances in cortical GABAergic microcircuits, which are thought to underlie cognitive impairments in schizophrenia.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
"One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle," said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. "If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women."
› Verified 2 days ago
| Entity Name | Seven Hills Ob-gyn Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609856525 PECOS PAC ID: 0749188142 Enrollment ID: O20040128000116 |
News Archive
Working with lab mice models of multiple sclerosis, UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
New research by scientists at the University of Pittsburgh provides an unprecedented level of resolution and insight into disturbances in cortical GABAergic microcircuits, which are thought to underlie cognitive impairments in schizophrenia.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
"One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle," said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. "If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna S Zabrecky, MD 7495 State Rd, Ste 300, Cincinnati, OH 45255-6402 Ph: (513) 231-3447 | Dr Anna S Zabrecky, MD 7495 State Rd, Ste 300, Cincinnati, OH 45255-6402 Ph: (513) 231-3447 |
News Archive
Working with lab mice models of multiple sclerosis, UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
New research by scientists at the University of Pittsburgh provides an unprecedented level of resolution and insight into disturbances in cortical GABAergic microcircuits, which are thought to underlie cognitive impairments in schizophrenia.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
"One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle," said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. "If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women."
› Verified 2 days ago
Ellen W Feld, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8231 Cornell Rd, Suite 320, Cincinnati, OH 45249 Phone: 513-794-1500 Fax: 513-794-1500 | |
Renee Louise Klee, CNM Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7495 State Rd, Suite 300, Cincinnati, OH 45255 Phone: 513-231-3447 Fax: 513-231-3761 | |
Dr. Laura Hampel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10475 Reading Rd, Cincinnati, OH 45241 Phone: 513-563-2202 Fax: 513-751-2327 | |
Helmut F Schellhas, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-862-1888 Fax: 513-862-3616 | |
Dr. Sarah E Bartlett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8350 E Kemper Rd Ste A, Cincinnati, OH 45249 Phone: 513-404-4166 | |
Anuja Gupta, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8000 5 Mile Rd Ste 207, Cincinnati, OH 45230 Phone: 513-474-2870 Fax: 513-688-8585 | |
Dr. Ajit Gubbi, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 Ivy Gtwy Ste 1100, Cincinnati, OH 45245 Phone: 513-751-2273 Fax: 513-751-1840 |